Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001178913-18-002109
Filing Date
2018-07-23
Accepted
2018-07-23 06:32:01
Documents
17
Period of Report
2018-07-23

Document Format Files

Seq Description Document Type Size
1 6-K zk1821905.htm 6-K 279755
8 image00001.jpg GRAPHIC 3225
  Complete submission text file 0001178913-18-002109.txt   661991

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE DOCUMENT trib-20180630.xml EX-101.INS 37301
3 XBRL TAXONOMY EXTENSION SCHEMA trib-20180630.xsd EX-101.SCH 6327
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE trib-20180630_cal.xml EX-101.CAL 18918
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE trib-20180630_def.xml EX-101.DEF 3116
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE trib-20180630_lab.xml EX-101.LAB 60033
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE trib-20180630_pre.xml EX-101.PRE 36147
Mailing Address 3 ROCK ROAD SANDYFORD INDUSTRIAL ESTATES DUBLIN IRELAND L2 18
Business Address IDA BUSINESS PARK, BRAY, CO WICKLOW IRELAND DUBLIN IRELAND L2 18 01135312955111
TRINITY BIOTECH PLC (Filer) CIK: 0000888721 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-22320 | Film No.: 18963567
SIC: 2835 In Vitro & In Vivo Diagnostic Substances